Welcome to our dedicated page for CURALEAF HLDGS news (Ticker: CURLF), a resource for investors and traders seeking the latest updates and insights on CURALEAF HLDGS stock.
Curaleaf Holdings, Inc. (CURLF) is a prominent international provider of consumer cannabis products, known for its mission to enhance lives by sharing and celebrating the power of the plant. It operates under various brands like Curaleaf, Select, Grassroots, JAMS, Find, and Zero Proof in the medical and adult-use markets. With operations in over 15 countries globally, Curaleaf focuses on quality, expertise, and accessibility in the cannabis industry.
Recently, Curaleaf announced a strategic acquisition of Northern Green Canada, a licensed Canadian cannabis producer with a focus on international market expansion. This move aligns with Curaleaf's vision of becoming a global cannabis company with a strong presence in North America, Europe, and Australasia. The acquisition of NGC provides Curaleaf with EU-GMP certification, enabling the company to strengthen its supply chain, improve margins, and extend its global footprint.
Under the leadership of Boris Jordan, Executive Chairman, and Matt Darin, CEO, Curaleaf continues to drive growth and innovation within the cannabis space. The company's commitment to delivering high-quality products and patient access remains a top priority in evolving markets and regulatory environments.
Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) has launched medical cannabis products through its subsidiary Adven GmbH in Germany, the largest medical cannabis market in Europe. The initial offering features a high THC oil product, with plans to expand to more formulations throughout the year, addressing diverse patient needs. The German market for medical cannabis is projected to reach US$2.1 billion by 2025, highlighting significant growth opportunities for Curaleaf in Europe.
Curaleaf Holdings reported strong financial results for Q1 2021, with total revenue reaching $260.3 million, a 170% increase year-over-year. Gross profit on cannabis sales rose to $128 million, achieving a gross margin of 49%. Despite a net loss of $17.2 million, the company cited record adjusted EBITDA of $62.6 million and raised approximately $300 million in new capital. Curaleaf's strategic investments and product launches, such as the Select Squeeze THC-infused beverage enhancer, bolster its market position. The company anticipates revenue of $305 million to $315 million in Q2 2021.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) has completed a significant reorganization of its Maryland operations, enhancing its position as a top cannabis operator in the state. The company acquired Maryland Compassionate Care and Wellness, LLC, which operates a 55,000 sq ft cultivation and processing facility in Taneytown, and a dispensary in Gaithersburg. Curaleaf also sold its interests in other facilities for a total of $31.4 million, including $27.5 million from TerrAscend and $3.9 million from PharmaCann. This expansion aims to boost production capacity and patient access in Maryland.
Curaleaf Holdings (CSE: CURA / OTCQX: CURLF) has announced participation in several upcoming investor conferences in May 2021. CEO Joe Bayern will speak at A.G.P.'s Spring Virtual Consumer Cannabis Conference on May 4, focusing on new adult-use markets in New York and New Jersey. Executive Chairman Boris Jordan will take part in Canaccord's Cannabis Conference on May 11, and a discussion on Curaleaf's European expansion at Prohibition Partners LIVE on May 20. More details are available on their IR website.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) has opened its first adult-use retail location in South Portland, Maine, expanding its total to 106 stores. The new location offers Curaleaf's renowned products, including Select, and aims to serve the growing adult-use market. The company has operated in Maine since 2014, focusing on quality and customer service. Curaleaf is committed to community support through initiatives like job inclusivity and social equity programs, including significant local donations. The opening celebration features discounts and contributions to local charities.
Curaleaf Holdings announced it will release its financial and operational results for Q1 2021 on May 10, 2021, after market close. A conference call is scheduled for the same evening at 5:00 p.m. ET, featuring remarks from management and a Q&A session. Curaleaf operates in 23 states with 105 dispensaries and is recognized as a leading cannabis producer. Interested participants can access a replay until May 17, 2021. For more details, visit their website.
Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) announces the opening of two new retail locations in Horsham and Philadelphia, marking its 11th and 12th stores in Pennsylvania. This expansion brings Curaleaf's total to 104 locations nationwide across 23 states. The company recently rebranded nine Herbology dispensaries under the Curaleaf name. CEO Joe Bayern anticipates strong demand for cannabis products, highlighting Curaleaf's commitment to community engagement and patient care through various CSR initiatives, including discounts for veterans and first-time patients.
Curaleaf has successfully acquired EMMAC Life Sciences for approximately US$50 million in cash and 17.5 million shares. This makes Curaleaf the largest vertically integrated cannabis company in Europe, enhancing its presence across key markets including the UK, Germany, and Italy. Additionally, Curaleaf secured a US$130 million investment from a strategic investor for a 31.5% stake in its new entity, Curaleaf International, valuing it at US$413 million. This capital will fund the acquisition and support Curaleaf's expansion in Europe, aiming to significantly increase cultivation capacity.
Curaleaf Holdings announces the opening of its 10th retail store in Illinois, located in Westmont, marking a total of 103 locations nationwide. The company has rebranded nine acquired stores in Illinois, enhancing community connection through local designs. Curaleaf also invested $950,000 in social equity initiatives in the Chicago area, focusing on education and job training. The Grand Opening event on April 8 will feature discounts and community engagement. CEO Joe Bayern emphasizes building strong national brands and partnerships to positively impact communities.
Curaleaf, a leading cannabis company, launched Select Squeeze, a THC-infused beverage enhancer that uses nano-emulsification technology, on March 23, 2021. This product marks a significant milestone as it becomes available in 14 states for a total accessible audience of 94 million adults. With faster absorption rates than traditional edibles, Select Squeeze is designed for easy dosing and discreet use. The product will feature four flavors and will be part of a larger lineup in over 1,500 locations. Curaleaf continues to expand its presence nationwide, solidifying its status in the cannabis market.
FAQ
What is the current stock price of CURALEAF HLDGS (CURLF)?
What is the market cap of CURALEAF HLDGS (CURLF)?
What is Curaleaf Holdings, Inc. known for?
Who are the key leaders at Curaleaf?
What recent acquisition has Curaleaf made?
Where does Curaleaf operate?
